, /PRNewswire/ -- AbbVie (NYSE: ) today launched the , a first-of-its-kind contest designed to support the career, workplace, and professional development aspirations of people living with migraine. With more than 113 million workdays lost in the U.S.
each year to the disease and its symptoms, migraine can have a major impact in the workplace. Twenty contest entrants will win up to that they can decide to use toward career support, including career counseling, professional development programs, and networking opportunities. Visit the website to learn more and enter: .
"With the launch of the AbbVie Migraine Career Catalyst Award, we're taking our commitment to the migraine community beyond the medicine and hoping to empower migraine patients to pursue their career goals with confidence," said Jag Dosanjh, senior vice president, AbbVie, and president, neuroscience and eye care. "While migraine has a significant impact on many areas of life, including work, we are proud to support people living with the disease as they strive for migraine freedom." Migraine is the world's second leading cause of disability , impacting millions of people worldwide and nearly 40 million in the U.
S. alone. In the workplace specifically, findings from the Chronic Migraine Epidemiology and Outcomes (CaMEO) study, and more recent findings from the CaMEO-International study, revealed substantial stigma against people living with migraine, with many feeling that co-workers and supervisors perceive thei.
